Prevalence, incidence and carrier frequency of 5q–linked spinal muscular atrophy – a literature review View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2017-07-04

AUTHORS

Ingrid E. C. Verhaart, Agata Robertson, Ian J. Wilson, Annemieke Aartsma-Rus, Shona Cameron, Cynthia C. Jones, Suzanne F. Cook, Hanns Lochmüller

ABSTRACT

Spinal muscular atrophy linked to chromosome 5q (SMA) is a recessive, progressive, neuromuscular disorder caused by bi-allelic mutations in the SMN1 gene, resulting in motor neuron degeneration and variable presentation in relation to onset and severity. A prevalence of approximately 1-2 per 100,000 persons and incidence around 1 in 10,000 live births have been estimated with SMA type I accounting for around 60% of all cases. Since SMA is a relatively rare condition, studies of its prevalence and incidence are challenging. Most published studies are outdated and therefore rely on clinical rather than genetic diagnosis. Furthermore they are performed in small cohorts in small geographical regions and only study European populations. In addition, the heterogeneity of the condition can lead to delays and difficulties in diagnosing the condition, especially outside of specialist clinics, and contributes to the challenges in understanding the epidemiology of the disease. The frequency of unaffected, heterozygous carriers of the SMN1 mutations appears to be higher among Caucasian and Asian populations compared to the Black (Sub-Saharan African ancestry) population. However, carrier frequencies cannot directly be translated into incidence and prevalence, as very severe (death in utero) and very mild (symptom free in adults) phenotypes carrying bi-allelic SMN1 mutations exist, and their frequency is unknown. More robust epidemiological data on SMA covering larger populations based on accurate genetic diagnosis or newborn screening would be helpful to support planning of clinical studies, provision of care and therapies and evaluation of outcomes. More... »

PAGES

124

References to SciGraph publications

  • 2012-01-25. Homozygous SMN2 deletion is a protective factor in the Swedish ALS population in EUROPEAN JOURNAL OF HUMAN GENETICS
  • 1990-07. Population data on acute infantile and chronic childhood spinal muscular atrophy in Warsaw in HUMAN GENETICS
  • 2011-08-03. Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72 400 specimens in EUROPEAN JOURNAL OF HUMAN GENETICS
  • 2004-09. Carrier incidence for spinal muscular atrophy in southern Chinese in JOURNAL OF NEUROLOGY
  • 2014-02-20. Carrier screening for spinal muscular atrophy in Italian population in JOURNAL OF GENETICS
  • 1993-04. Epidemiological data on Werdnig-Hoffmann disease in Germany (West-Thüringen) in HUMAN GENETICS
  • 2011-05-25. A common spinal muscular atrophy deletion mutation is present on a single founder haplotype in the US Hutterites in EUROPEAN JOURNAL OF HUMAN GENETICS
  • 2008-12-03. Mutation update of spinal muscular atrophy in Spain: molecular characterization of 745 unrelated patients and identification of four novel mutations in the SMN1 gene in HUMAN GENETICS
  • 1994-03. Chronic childhood spinal muscular atrophy in Germany (West-Thüringen) — an epidemiological study in HUMAN GENETICS
  • 2015-10-29. Validation of a high resolution NGS method for detecting spinal muscular atrophy carriers among phase 3 participants in the 1000 Genomes Project in BMC MEDICAL GENETICS
  • 2004-10-06. New insights on the evolution of the SMN1 and SMN2 region: simulation and meta-analysis for allele and haplotype frequency calculations in EUROPEAN JOURNAL OF HUMAN GENETICS
  • 2007-04. Copy number analysis of survival motor neuron genes by multiplex ligation-dependent probe amplification in GENETICS IN MEDICINE
  • 2002-02. Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2 in GENETICS IN MEDICINE
  • 2015-04-16. The Israeli national population program of genetic carrier screening for reproductive purposes in GENETICS IN MEDICINE
  • 2006-03-01. Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number in HUMAN GENETICS
  • 2011-06-13. Technical standards and guidelines for spinal muscular atrophy testing in GENETICS IN MEDICINE
  • 2011-01-11. Large-scale population screening for spinal muscular atrophy: Clinical implications in GENETICS IN MEDICINE
  • 2013-06-20. An Ashkenazi Jewish SMN1 haplotype specific to duplication alleles improves pan-ethnic carrier screening for spinal muscular atrophy in GENETICS IN MEDICINE
  • 2007-03-28. Population screening and cascade testing for carriers of SMA in EUROPEAN JOURNAL OF HUMAN GENETICS
  • 1988-09. A clinical, epidemiological and genetic study of hereditary motor neuropathies in Benghazi, Libya in JOURNAL OF NEUROLOGY
  • 2008-03-12. Unaffected patients with a homozygous absence of the SMN1 gene in EUROPEAN JOURNAL OF HUMAN GENETICS
  • 2010-05-05. Molecular characterization of SMN copy number derived from carrier screening and from core families with SMA in a Chinese population in EUROPEAN JOURNAL OF HUMAN GENETICS
  • 1998-09. Identification of a candidate modifying gene for spinal muscular atrophy by comparative genomics in NATURE GENETICS
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1186/s13023-017-0671-8

    DOI

    http://dx.doi.org/10.1186/s13023-017-0671-8

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1090386228

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/28676062


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Public Health and Health Services", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Chromosomes, Human, Pair 5", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Incidence", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Muscular Atrophy, Spinal", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Prevalence", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Survival of Motor Neuron 1 Protein", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK", 
              "id": "http://www.grid.ac/institutes/grid.1006.7", 
              "name": [
                "John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Verhaart", 
            "givenName": "Ingrid E. C.", 
            "id": "sg:person.01036235277.10", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036235277.10"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK", 
              "id": "http://www.grid.ac/institutes/grid.1006.7", 
              "name": [
                "John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Robertson", 
            "givenName": "Agata", 
            "id": "sg:person.015050646173.21", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015050646173.21"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK", 
              "id": "http://www.grid.ac/institutes/grid.1006.7", 
              "name": [
                "Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Wilson", 
            "givenName": "Ian J.", 
            "id": "sg:person.014722271013.73", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014722271013.73"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK", 
              "id": "http://www.grid.ac/institutes/grid.1006.7", 
              "name": [
                "John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Aartsma-Rus", 
            "givenName": "Annemieke", 
            "id": "sg:person.0676166526.16", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676166526.16"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK", 
              "id": "http://www.grid.ac/institutes/grid.1006.7", 
              "name": [
                "John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Cameron", 
            "givenName": "Shona", 
            "id": "sg:person.016402552206.30", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016402552206.30"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Biogen MA Inc., Cambridge, USA", 
              "id": "http://www.grid.ac/institutes/grid.417832.b", 
              "name": [
                "Biogen MA Inc., Cambridge, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Jones", 
            "givenName": "Cynthia C.", 
            "id": "sg:person.011333476773.19", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011333476773.19"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Epidemiology Associates LLC, Chapel Hill, USA", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Epidemiology Associates LLC, Chapel Hill, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Cook", 
            "givenName": "Suzanne F.", 
            "id": "sg:person.012131057373.79", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012131057373.79"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "John Walton Muscular Dystrophy Research Centre, MRC Centre for Neuromuscular Diseases, Institute of Genetic Medicine, Newcastle University, Central Parkway, Newcastle upon Tyne, NE1 3BZ UK", 
              "id": "http://www.grid.ac/institutes/grid.1006.7", 
              "name": [
                "John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK", 
                "John Walton Muscular Dystrophy Research Centre, MRC Centre for Neuromuscular Diseases, Institute of Genetic Medicine, Newcastle University, Central Parkway, Newcastle upon Tyne, NE1 3BZ UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Lochm\u00fcller", 
            "givenName": "Hanns", 
            "id": "sg:person.015416721437.85", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015416721437.85"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/bf00314486", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1021897986", 
              "https://doi.org/10.1007/bf00314486"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12041-014-0323-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1016625971", 
              "https://doi.org/10.1007/s12041-014-0323-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/gim.2013.84", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1026075151", 
              "https://doi.org/10.1038/gim.2013.84"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00439-008-0598-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049495929", 
              "https://doi.org/10.1007/s00439-008-0598-1"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1097/gim.0b013e318220d523", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1046859928", 
              "https://doi.org/10.1097/gim.0b013e318220d523"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/ejhg.2010.54", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035365547", 
              "https://doi.org/10.1038/ejhg.2010.54"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.ejhg.5201821", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1044885285", 
              "https://doi.org/10.1038/sj.ejhg.5201821"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1097/00125817-200201000-00004", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001771934", 
              "https://doi.org/10.1097/00125817-200201000-00004"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/gim.2015.55", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1039339315", 
              "https://doi.org/10.1038/gim.2015.55"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/ejhg.2011.85", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1053005737", 
              "https://doi.org/10.1038/ejhg.2011.85"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf00218278", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1010705303", 
              "https://doi.org/10.1007/bf00218278"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/1753", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1052917072", 
              "https://doi.org/10.1038/1753"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/ejhg.2008.41", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001360851", 
              "https://doi.org/10.1038/ejhg.2008.41"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf00193198", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1022027172", 
              "https://doi.org/10.1007/bf00193198"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s12881-015-0246-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1031634945", 
              "https://doi.org/10.1186/s12881-015-0246-2"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1097/gim.0b013e31803d35bc", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1052594034", 
              "https://doi.org/10.1097/gim.0b013e31803d35bc"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/ejhg.2011.134", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1050720483", 
              "https://doi.org/10.1038/ejhg.2011.134"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf00212036", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002540142", 
              "https://doi.org/10.1007/bf00212036"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00439-006-0156-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001783816", 
              "https://doi.org/10.1007/s00439-006-0156-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1097/gim.0b013e3182017c05", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1052239503", 
              "https://doi.org/10.1097/gim.0b013e3182017c05"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00415-004-0487-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1024458015", 
              "https://doi.org/10.1007/s00415-004-0487-z"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/ejhg.2011.255", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013359425", 
              "https://doi.org/10.1038/ejhg.2011.255"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.ejhg.5201288", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1010300482", 
              "https://doi.org/10.1038/sj.ejhg.5201288"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2017-07-04", 
        "datePublishedReg": "2017-07-04", 
        "description": "Spinal muscular atrophy linked to chromosome 5q (SMA) is a recessive, progressive, neuromuscular disorder caused by bi-allelic mutations in the SMN1 gene, resulting in motor neuron degeneration and variable presentation in relation to onset and severity. A prevalence of approximately 1-2 per 100,000 persons and incidence around 1 in 10,000 live births have been estimated with SMA type I accounting for around 60% of all cases. Since SMA is a relatively rare condition, studies of its prevalence and incidence are challenging. Most published studies are outdated and therefore rely on clinical rather than genetic diagnosis. Furthermore they are performed in small cohorts in small geographical regions and only study European populations. In addition, the heterogeneity of the condition can lead to delays and difficulties in diagnosing the condition, especially outside of specialist clinics, and contributes to the challenges in understanding the epidemiology of the disease. The frequency of unaffected, heterozygous carriers of the SMN1 mutations appears to be higher among Caucasian and Asian populations compared to the Black (Sub-Saharan African ancestry) population. However, carrier frequencies cannot directly be translated into incidence and prevalence, as very severe (death in utero) and very mild (symptom free in adults) phenotypes carrying bi-allelic SMN1 mutations exist, and their frequency is unknown. More robust epidemiological data on SMA covering larger populations based on accurate genetic diagnosis or newborn screening would be helpful to support planning of clinical studies, provision of care and therapies and evaluation of outcomes.", 
        "genre": "article", 
        "id": "sg:pub.10.1186/s13023-017-0671-8", 
        "inLanguage": "en", 
        "isAccessibleForFree": true, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.2436561", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2699478", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1036535", 
            "issn": [
              "1750-1172"
            ], 
            "name": "Orphanet Journal of Rare Diseases", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "12"
          }
        ], 
        "keywords": [
          "spinal muscular atrophy", 
          "muscular atrophy", 
          "motor neuron degeneration", 
          "robust epidemiological data", 
          "SMA type I", 
          "SMN1 mutations", 
          "genetic diagnosis", 
          "provision of care", 
          "evaluation of outcomes", 
          "neuron degeneration", 
          "rare condition", 
          "specialist clinic", 
          "bi-allelic mutations", 
          "variable presentation", 
          "clinical studies", 
          "live births", 
          "epidemiological data", 
          "small cohort", 
          "neuromuscular disorders", 
          "newborn screening", 
          "prevalence", 
          "incidence", 
          "accurate genetic diagnosis", 
          "heterozygous carriers", 
          "SMN1 gene", 
          "Asian populations", 
          "mild phenotype", 
          "atrophy", 
          "type I", 
          "diagnosis", 
          "black population", 
          "chromosome 5q", 
          "population", 
          "literature review", 
          "large population", 
          "European populations", 
          "mutations", 
          "SMA", 
          "clinic", 
          "therapy", 
          "cohort", 
          "epidemiology", 
          "degeneration", 
          "disease", 
          "severity", 
          "study", 
          "care", 
          "disorders", 
          "birth", 
          "outcomes", 
          "onset", 
          "presentation", 
          "geographical regions", 
          "screening", 
          "frequency", 
          "phenotype", 
          "review", 
          "persons", 
          "evaluation", 
          "cases", 
          "genes", 
          "small geographical region", 
          "heterogeneity", 
          "conditions", 
          "carriers", 
          "addition", 
          "data", 
          "difficulties", 
          "provision", 
          "delay", 
          "carrier frequency", 
          "challenges", 
          "planning", 
          "region", 
          "relation", 
          "allelic SMN1 mutations"
        ], 
        "name": "Prevalence, incidence and carrier frequency of 5q\u2013linked spinal muscular atrophy \u2013 a literature review", 
        "pagination": "124", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1090386228"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1186/s13023-017-0671-8"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "28676062"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1186/s13023-017-0671-8", 
          "https://app.dimensions.ai/details/publication/pub.1090386228"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2021-12-01T19:39", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_726.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1186/s13023-017-0671-8"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s13023-017-0671-8'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s13023-017-0671-8'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s13023-017-0671-8'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s13023-017-0671-8'


     

    This table displays all metadata directly associated to this object as RDF triples.

    324 TRIPLES      22 PREDICATES      133 URIs      102 LITERALS      15 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1186/s13023-017-0671-8 schema:about N129d2297c7dd495db6ab73164e9abd02
    2 N372502bc04d84a2898f9863bb9678fd6
    3 N42cf25f613a24b15957a67a85a8e46e1
    4 N46160500100f4d97901c19bd0144d0ad
    5 N5506e53329fc433995c24d606eedbbd7
    6 N8b6554585d9d48d6bd5ef8c33f9ec324
    7 Nda424da3b83e464d99a239806bd27501
    8 Ne8c6dec68d514b69aef0744b2138bfcb
    9 anzsrc-for:11
    10 anzsrc-for:1117
    11 schema:author N74d4bff27f5d4ccfa32ba92d39e70a1d
    12 schema:citation sg:pub.10.1007/bf00193198
    13 sg:pub.10.1007/bf00212036
    14 sg:pub.10.1007/bf00218278
    15 sg:pub.10.1007/bf00314486
    16 sg:pub.10.1007/s00415-004-0487-z
    17 sg:pub.10.1007/s00439-006-0156-7
    18 sg:pub.10.1007/s00439-008-0598-1
    19 sg:pub.10.1007/s12041-014-0323-x
    20 sg:pub.10.1038/1753
    21 sg:pub.10.1038/ejhg.2008.41
    22 sg:pub.10.1038/ejhg.2010.54
    23 sg:pub.10.1038/ejhg.2011.134
    24 sg:pub.10.1038/ejhg.2011.255
    25 sg:pub.10.1038/ejhg.2011.85
    26 sg:pub.10.1038/gim.2013.84
    27 sg:pub.10.1038/gim.2015.55
    28 sg:pub.10.1038/sj.ejhg.5201288
    29 sg:pub.10.1038/sj.ejhg.5201821
    30 sg:pub.10.1097/00125817-200201000-00004
    31 sg:pub.10.1097/gim.0b013e31803d35bc
    32 sg:pub.10.1097/gim.0b013e3182017c05
    33 sg:pub.10.1097/gim.0b013e318220d523
    34 sg:pub.10.1186/s12881-015-0246-2
    35 schema:datePublished 2017-07-04
    36 schema:datePublishedReg 2017-07-04
    37 schema:description Spinal muscular atrophy linked to chromosome 5q (SMA) is a recessive, progressive, neuromuscular disorder caused by bi-allelic mutations in the SMN1 gene, resulting in motor neuron degeneration and variable presentation in relation to onset and severity. A prevalence of approximately 1-2 per 100,000 persons and incidence around 1 in 10,000 live births have been estimated with SMA type I accounting for around 60% of all cases. Since SMA is a relatively rare condition, studies of its prevalence and incidence are challenging. Most published studies are outdated and therefore rely on clinical rather than genetic diagnosis. Furthermore they are performed in small cohorts in small geographical regions and only study European populations. In addition, the heterogeneity of the condition can lead to delays and difficulties in diagnosing the condition, especially outside of specialist clinics, and contributes to the challenges in understanding the epidemiology of the disease. The frequency of unaffected, heterozygous carriers of the SMN1 mutations appears to be higher among Caucasian and Asian populations compared to the Black (Sub-Saharan African ancestry) population. However, carrier frequencies cannot directly be translated into incidence and prevalence, as very severe (death in utero) and very mild (symptom free in adults) phenotypes carrying bi-allelic SMN1 mutations exist, and their frequency is unknown. More robust epidemiological data on SMA covering larger populations based on accurate genetic diagnosis or newborn screening would be helpful to support planning of clinical studies, provision of care and therapies and evaluation of outcomes.
    38 schema:genre article
    39 schema:inLanguage en
    40 schema:isAccessibleForFree true
    41 schema:isPartOf N18efb32fb5444af1a60aa3d801d3f17d
    42 Ndcec4762a83c429ca8fa44e2579d15de
    43 sg:journal.1036535
    44 schema:keywords Asian populations
    45 European populations
    46 SMA
    47 SMA type I
    48 SMN1 gene
    49 SMN1 mutations
    50 accurate genetic diagnosis
    51 addition
    52 allelic SMN1 mutations
    53 atrophy
    54 bi-allelic mutations
    55 birth
    56 black population
    57 care
    58 carrier frequency
    59 carriers
    60 cases
    61 challenges
    62 chromosome 5q
    63 clinic
    64 clinical studies
    65 cohort
    66 conditions
    67 data
    68 degeneration
    69 delay
    70 diagnosis
    71 difficulties
    72 disease
    73 disorders
    74 epidemiological data
    75 epidemiology
    76 evaluation
    77 evaluation of outcomes
    78 frequency
    79 genes
    80 genetic diagnosis
    81 geographical regions
    82 heterogeneity
    83 heterozygous carriers
    84 incidence
    85 large population
    86 literature review
    87 live births
    88 mild phenotype
    89 motor neuron degeneration
    90 muscular atrophy
    91 mutations
    92 neuromuscular disorders
    93 neuron degeneration
    94 newborn screening
    95 onset
    96 outcomes
    97 persons
    98 phenotype
    99 planning
    100 population
    101 presentation
    102 prevalence
    103 provision
    104 provision of care
    105 rare condition
    106 region
    107 relation
    108 review
    109 robust epidemiological data
    110 screening
    111 severity
    112 small cohort
    113 small geographical region
    114 specialist clinic
    115 spinal muscular atrophy
    116 study
    117 therapy
    118 type I
    119 variable presentation
    120 schema:name Prevalence, incidence and carrier frequency of 5q–linked spinal muscular atrophy – a literature review
    121 schema:pagination 124
    122 schema:productId N4b54a1ac77ec4619a3929ba226d7a7b6
    123 N93e4c0405ac64927ab0bfb4c9ec831b8
    124 Nd23c3e9e256644499d474ed4fd5ed557
    125 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090386228
    126 https://doi.org/10.1186/s13023-017-0671-8
    127 schema:sdDatePublished 2021-12-01T19:39
    128 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    129 schema:sdPublisher N3baa9e4161274d00b1ba87b7aaad9fd7
    130 schema:url https://doi.org/10.1186/s13023-017-0671-8
    131 sgo:license sg:explorer/license/
    132 sgo:sdDataset articles
    133 rdf:type schema:ScholarlyArticle
    134 N129d2297c7dd495db6ab73164e9abd02 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    135 schema:name Female
    136 rdf:type schema:DefinedTerm
    137 N18efb32fb5444af1a60aa3d801d3f17d schema:issueNumber 1
    138 rdf:type schema:PublicationIssue
    139 N2399e8bd0a664c5098e3f73701e6d44d rdf:first sg:person.016402552206.30
    140 rdf:rest N9b5541b62a7349b891dd41691a8409ba
    141 N372502bc04d84a2898f9863bb9678fd6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    142 schema:name Incidence
    143 rdf:type schema:DefinedTerm
    144 N3baa9e4161274d00b1ba87b7aaad9fd7 schema:name Springer Nature - SN SciGraph project
    145 rdf:type schema:Organization
    146 N42cf25f613a24b15957a67a85a8e46e1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    147 schema:name Humans
    148 rdf:type schema:DefinedTerm
    149 N46160500100f4d97901c19bd0144d0ad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    150 schema:name Muscular Atrophy, Spinal
    151 rdf:type schema:DefinedTerm
    152 N4b54a1ac77ec4619a3929ba226d7a7b6 schema:name pubmed_id
    153 schema:value 28676062
    154 rdf:type schema:PropertyValue
    155 N505d6a658c88412faf63d021007465d0 rdf:first sg:person.012131057373.79
    156 rdf:rest N8dd71d500a534cdca2e46610e6dd5e6f
    157 N5506e53329fc433995c24d606eedbbd7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    158 schema:name Chromosomes, Human, Pair 5
    159 rdf:type schema:DefinedTerm
    160 N74d4bff27f5d4ccfa32ba92d39e70a1d rdf:first sg:person.01036235277.10
    161 rdf:rest Na8ae7c12e8a34887b502e6c0c298f332
    162 N8b6554585d9d48d6bd5ef8c33f9ec324 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    163 schema:name Male
    164 rdf:type schema:DefinedTerm
    165 N8dd71d500a534cdca2e46610e6dd5e6f rdf:first sg:person.015416721437.85
    166 rdf:rest rdf:nil
    167 N93e4c0405ac64927ab0bfb4c9ec831b8 schema:name doi
    168 schema:value 10.1186/s13023-017-0671-8
    169 rdf:type schema:PropertyValue
    170 N9b5541b62a7349b891dd41691a8409ba rdf:first sg:person.011333476773.19
    171 rdf:rest N505d6a658c88412faf63d021007465d0
    172 Na8ae7c12e8a34887b502e6c0c298f332 rdf:first sg:person.015050646173.21
    173 rdf:rest Nefb7c4e419d74cfe8a1dce6f8858a7ca
    174 Na9271bd3d7014713a6dd1d9493ca341b rdf:first sg:person.0676166526.16
    175 rdf:rest N2399e8bd0a664c5098e3f73701e6d44d
    176 Nd23c3e9e256644499d474ed4fd5ed557 schema:name dimensions_id
    177 schema:value pub.1090386228
    178 rdf:type schema:PropertyValue
    179 Nda424da3b83e464d99a239806bd27501 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    180 schema:name Prevalence
    181 rdf:type schema:DefinedTerm
    182 Ndcec4762a83c429ca8fa44e2579d15de schema:volumeNumber 12
    183 rdf:type schema:PublicationVolume
    184 Ne8c6dec68d514b69aef0744b2138bfcb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    185 schema:name Survival of Motor Neuron 1 Protein
    186 rdf:type schema:DefinedTerm
    187 Nefb7c4e419d74cfe8a1dce6f8858a7ca rdf:first sg:person.014722271013.73
    188 rdf:rest Na9271bd3d7014713a6dd1d9493ca341b
    189 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    190 schema:name Medical and Health Sciences
    191 rdf:type schema:DefinedTerm
    192 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
    193 schema:name Public Health and Health Services
    194 rdf:type schema:DefinedTerm
    195 sg:grant.2436561 http://pending.schema.org/fundedItem sg:pub.10.1186/s13023-017-0671-8
    196 rdf:type schema:MonetaryGrant
    197 sg:grant.2699478 http://pending.schema.org/fundedItem sg:pub.10.1186/s13023-017-0671-8
    198 rdf:type schema:MonetaryGrant
    199 sg:journal.1036535 schema:issn 1750-1172
    200 schema:name Orphanet Journal of Rare Diseases
    201 schema:publisher Springer Nature
    202 rdf:type schema:Periodical
    203 sg:person.01036235277.10 schema:affiliation grid-institutes:grid.1006.7
    204 schema:familyName Verhaart
    205 schema:givenName Ingrid E. C.
    206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036235277.10
    207 rdf:type schema:Person
    208 sg:person.011333476773.19 schema:affiliation grid-institutes:grid.417832.b
    209 schema:familyName Jones
    210 schema:givenName Cynthia C.
    211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011333476773.19
    212 rdf:type schema:Person
    213 sg:person.012131057373.79 schema:affiliation grid-institutes:None
    214 schema:familyName Cook
    215 schema:givenName Suzanne F.
    216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012131057373.79
    217 rdf:type schema:Person
    218 sg:person.014722271013.73 schema:affiliation grid-institutes:grid.1006.7
    219 schema:familyName Wilson
    220 schema:givenName Ian J.
    221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014722271013.73
    222 rdf:type schema:Person
    223 sg:person.015050646173.21 schema:affiliation grid-institutes:grid.1006.7
    224 schema:familyName Robertson
    225 schema:givenName Agata
    226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015050646173.21
    227 rdf:type schema:Person
    228 sg:person.015416721437.85 schema:affiliation grid-institutes:grid.1006.7
    229 schema:familyName Lochmüller
    230 schema:givenName Hanns
    231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015416721437.85
    232 rdf:type schema:Person
    233 sg:person.016402552206.30 schema:affiliation grid-institutes:grid.1006.7
    234 schema:familyName Cameron
    235 schema:givenName Shona
    236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016402552206.30
    237 rdf:type schema:Person
    238 sg:person.0676166526.16 schema:affiliation grid-institutes:grid.1006.7
    239 schema:familyName Aartsma-Rus
    240 schema:givenName Annemieke
    241 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676166526.16
    242 rdf:type schema:Person
    243 sg:pub.10.1007/bf00193198 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022027172
    244 https://doi.org/10.1007/bf00193198
    245 rdf:type schema:CreativeWork
    246 sg:pub.10.1007/bf00212036 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002540142
    247 https://doi.org/10.1007/bf00212036
    248 rdf:type schema:CreativeWork
    249 sg:pub.10.1007/bf00218278 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010705303
    250 https://doi.org/10.1007/bf00218278
    251 rdf:type schema:CreativeWork
    252 sg:pub.10.1007/bf00314486 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021897986
    253 https://doi.org/10.1007/bf00314486
    254 rdf:type schema:CreativeWork
    255 sg:pub.10.1007/s00415-004-0487-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1024458015
    256 https://doi.org/10.1007/s00415-004-0487-z
    257 rdf:type schema:CreativeWork
    258 sg:pub.10.1007/s00439-006-0156-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001783816
    259 https://doi.org/10.1007/s00439-006-0156-7
    260 rdf:type schema:CreativeWork
    261 sg:pub.10.1007/s00439-008-0598-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049495929
    262 https://doi.org/10.1007/s00439-008-0598-1
    263 rdf:type schema:CreativeWork
    264 sg:pub.10.1007/s12041-014-0323-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1016625971
    265 https://doi.org/10.1007/s12041-014-0323-x
    266 rdf:type schema:CreativeWork
    267 sg:pub.10.1038/1753 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052917072
    268 https://doi.org/10.1038/1753
    269 rdf:type schema:CreativeWork
    270 sg:pub.10.1038/ejhg.2008.41 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001360851
    271 https://doi.org/10.1038/ejhg.2008.41
    272 rdf:type schema:CreativeWork
    273 sg:pub.10.1038/ejhg.2010.54 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035365547
    274 https://doi.org/10.1038/ejhg.2010.54
    275 rdf:type schema:CreativeWork
    276 sg:pub.10.1038/ejhg.2011.134 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050720483
    277 https://doi.org/10.1038/ejhg.2011.134
    278 rdf:type schema:CreativeWork
    279 sg:pub.10.1038/ejhg.2011.255 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013359425
    280 https://doi.org/10.1038/ejhg.2011.255
    281 rdf:type schema:CreativeWork
    282 sg:pub.10.1038/ejhg.2011.85 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053005737
    283 https://doi.org/10.1038/ejhg.2011.85
    284 rdf:type schema:CreativeWork
    285 sg:pub.10.1038/gim.2013.84 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026075151
    286 https://doi.org/10.1038/gim.2013.84
    287 rdf:type schema:CreativeWork
    288 sg:pub.10.1038/gim.2015.55 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039339315
    289 https://doi.org/10.1038/gim.2015.55
    290 rdf:type schema:CreativeWork
    291 sg:pub.10.1038/sj.ejhg.5201288 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010300482
    292 https://doi.org/10.1038/sj.ejhg.5201288
    293 rdf:type schema:CreativeWork
    294 sg:pub.10.1038/sj.ejhg.5201821 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044885285
    295 https://doi.org/10.1038/sj.ejhg.5201821
    296 rdf:type schema:CreativeWork
    297 sg:pub.10.1097/00125817-200201000-00004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001771934
    298 https://doi.org/10.1097/00125817-200201000-00004
    299 rdf:type schema:CreativeWork
    300 sg:pub.10.1097/gim.0b013e31803d35bc schema:sameAs https://app.dimensions.ai/details/publication/pub.1052594034
    301 https://doi.org/10.1097/gim.0b013e31803d35bc
    302 rdf:type schema:CreativeWork
    303 sg:pub.10.1097/gim.0b013e3182017c05 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052239503
    304 https://doi.org/10.1097/gim.0b013e3182017c05
    305 rdf:type schema:CreativeWork
    306 sg:pub.10.1097/gim.0b013e318220d523 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046859928
    307 https://doi.org/10.1097/gim.0b013e318220d523
    308 rdf:type schema:CreativeWork
    309 sg:pub.10.1186/s12881-015-0246-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031634945
    310 https://doi.org/10.1186/s12881-015-0246-2
    311 rdf:type schema:CreativeWork
    312 grid-institutes:None schema:alternateName Epidemiology Associates LLC, Chapel Hill, USA
    313 schema:name Epidemiology Associates LLC, Chapel Hill, USA
    314 rdf:type schema:Organization
    315 grid-institutes:grid.1006.7 schema:alternateName Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK
    316 John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK
    317 John Walton Muscular Dystrophy Research Centre, MRC Centre for Neuromuscular Diseases, Institute of Genetic Medicine, Newcastle University, Central Parkway, Newcastle upon Tyne, NE1 3BZ UK
    318 schema:name Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK
    319 John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK
    320 John Walton Muscular Dystrophy Research Centre, MRC Centre for Neuromuscular Diseases, Institute of Genetic Medicine, Newcastle University, Central Parkway, Newcastle upon Tyne, NE1 3BZ UK
    321 rdf:type schema:Organization
    322 grid-institutes:grid.417832.b schema:alternateName Biogen MA Inc., Cambridge, USA
    323 schema:name Biogen MA Inc., Cambridge, USA
    324 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...